These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 10197036

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
    Testa RT, Petersen PJ, Jacobus NV, Sum PE, Lee VJ, Tally FP.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2270-7. PubMed ID: 8285606
    [Abstract] [Full Text] [Related]

  • 3. Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species.
    Johnson DM, Jones RN.
    Diagn Microbiol Infect Dis; 1996 Jan; 24(1):53-7. PubMed ID: 8988765
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
    Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT.
    Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The glycylcyclines: a comparative review with the tetracyclines.
    Zhanel GG, Homenuik K, Nichol K, Noreddin A, Vercaigne L, Embil J, Gin A, Karlowsky JA, Hoban DJ.
    Drugs; 2004 Apr; 64(1):63-88. PubMed ID: 14723559
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
    Sum PE, Petersen P.
    Bioorg Med Chem Lett; 1999 May 17; 9(10):1459-62. PubMed ID: 10360756
    [Abstract] [Full Text] [Related]

  • 8. N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci.
    Goldstein FW, Kitzis MD, Acar JF.
    Antimicrob Agents Chemother; 1994 Sep 17; 38(9):2218-20. PubMed ID: 7811053
    [Abstract] [Full Text] [Related]

  • 9. Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.
    Honeyman L, Ismail M, Nelson ML, Bhatia B, Bowser TE, Chen J, Mechiche R, Ohemeng K, Verma AK, Cannon EP, Macone A, Tanaka SK, Levy S.
    Antimicrob Agents Chemother; 2015 Nov 17; 59(11):7044-53. PubMed ID: 26349824
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE, Rybak MJ.
    Pharmacotherapy; 2006 Aug 17; 26(8):1099-110. PubMed ID: 16863487
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates.
    Gales AC, Jones RN.
    Diagn Microbiol Infect Dis; 2000 Jan 17; 36(1):19-36. PubMed ID: 10744364
    [Abstract] [Full Text] [Related]

  • 13. Tigecyclin--the first glycylcycline to undergo clinical development: an overview of in vitro activity compared to tetracycline.
    Felmingham D.
    J Chemother; 2005 Aug 17; 17 Suppl 1():5-11. PubMed ID: 16285353
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines.
    Tuckman M, Petersen PJ, Projan SJ.
    Microb Drug Resist; 2000 Aug 17; 6(4):277-82. PubMed ID: 11272255
    [Abstract] [Full Text] [Related]

  • 16. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
    Kenny GE, Cartwright FD.
    Antimicrob Agents Chemother; 1994 Nov 17; 38(11):2628-32. PubMed ID: 7872759
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tigecycline.
    Pankey GA.
    J Antimicrob Chemother; 2005 Sep 17; 56(3):470-80. PubMed ID: 16040625
    [Abstract] [Full Text] [Related]

  • 19. In vitro activities of two glycylcyclines against gram-positive bacteria.
    Eliopoulos GM, Wennersten CB, Cole G, Moellering RC.
    Antimicrob Agents Chemother; 1994 Mar 17; 38(3):534-41. PubMed ID: 8203851
    [Abstract] [Full Text] [Related]

  • 20. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
    Garrison MW, Neumiller JJ, Setter SM.
    Clin Ther; 2005 Jan 17; 27(1):12-22. PubMed ID: 15763603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.